UNSPSC 51342712: Peginterferon alfa-2b

This classification denotes a pegylated interferon alfa with the molecular formula C2H4NO2(C2H4O)N, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier G8RGG88B68. European Medicines Agency schedules peginterferon alfa-2b in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12549MIG. The term PEGINTERFERON ALFA-2B is an International Non-Proprietary Name or INN.

UNSPSC 51342712 Peginterferon alfa-2b is a Commodity code that captures pharmaceutical procurement by state and local health agencies, though recent opportunities show limited direct activity under this specific injectable immunosuppressant. The code's scope encompasses specialty pharmaceuticals and biologics procured by state health departments, county health systems, city public health agencies, and municipal fire-rescue departments for clinical and emergency response use. State and local buyers under related pharmaceutical codes are primarily state health and human services commissions, county public health departments, and municipal fire departments acquiring generic multi-source pharmaceuticals, over-the-counter products, naloxone, medical and first aid supplies, and direct-to-manufacturer prescription programs to support community health initiatives, emergency medical response, and pharmacy benefit management across their service populations.

Recent pharmaceutical procurement activity spans multiple jurisdictions with concentration in larger state health systems and municipal providers. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline, requiring vendors to supply through three authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act standards. Texas Health and Human Services Commission posted an RFI on April 3, 2026 exploring direct-to-manufacturer prescription programs and vendor capabilities for self-insured group health plans. The City of Tampa issued an IFB for medical and first aid supplies (169 line items for the Fire Department Rescue Division) due March 13, 2026, with an estimated contract value of $700,000.00 and a 5% bid discount for certified Small Local Business Enterprises. Seminole County, Florida solicited sealed bids for naloxone and safe drug deactivation systems (1,900 units of naloxone and 800 deactivation systems annually) with quarterly deliveries, due July 26, 2026. Activity appears concentrated among state procurement cooperatives, large municipal health and fire departments, and county public health systems in Florida, Texas, Minnesota, and Oregon.